Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1973 1
1978 1
1979 1
1983 1
1986 2
1987 1
1989 1
1990 1
2001 1
2002 1
2003 1
2004 1
2006 2
2007 1
2008 1
2009 1
2011 1
2012 1
2014 3
2015 2
2016 1
2018 2
2020 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Cremolini C, Antoniotti C, Rossini D, Lonardi S, Loupakis F, Pietrantonio F, Bordonaro R, Latiano TP, Tamburini E, Santini D, Passardi A, Marmorino F, Grande R, Aprile G, Zaniboni A, Murgioni S, Granetto C, Buonadonna A, Moretto R, Corallo S, Cordio S, Antonuzzo L, Tomasello G, Masi G, Ronzoni M, Di Donato S, Carlomagno C, Clavarezza M, Ritorto G, Mambrini A, Roselli M, Cupini S, Mammoliti S, Fenocchio E, Corgna E, Zagonel V, Fontanini G, Ugolini C, Boni L, Falcone A; GONO Foundation Investigators. Cremolini C, et al. Lancet Oncol. 2020 Apr;21(4):497-507. doi: 10.1016/S1470-2045(19)30862-9. Epub 2020 Mar 9. Lancet Oncol. 2020. PMID: 32164906 Free article. Clinical Trial.
Epidemiology of nursemaid's elbow.
Vitello S, Dvorkin R, Sattler S, Levy D, Ung L. Vitello S, et al. West J Emerg Med. 2014 Jul;15(4):554-7. doi: 10.5811/westjem.2014.1.20813. West J Emerg Med. 2014. PMID: 25035767 Free PMC article.
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.
Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crinò L, Benedetti G, Evangelista W, Fanchini L, Cortesi E, Picone V, Vitello S, Chiara S, Granetto C, Porcile G, Fioretto L, Orlandini C, Andreuccetti M, Masi G; Gruppo Oncologico Nord Ovest. Falcone A, et al. Among authors: vitello s. J Clin Oncol. 2007 May 1;25(13):1670-6. doi: 10.1200/JCO.2006.09.0928. J Clin Oncol. 2007. PMID: 17470860 Clinical Trial.
Memory B cell subpopulations in the aged.
Colonna-Romano G, Aquino A, Bulati M, Di Lorenzo G, Listì F, Vitello S, Lio D, Candore G, Clesi G, Caruso C. Colonna-Romano G, et al. Among authors: vitello s. Rejuvenation Res. 2006 Spring;9(1):149-52. doi: 10.1089/rej.2006.9.149. Rejuvenation Res. 2006. PMID: 16608412
B cell immunosenescence in the elderly and in centenarians.
Colonna-Romano G, Bulati M, Aquino A, Vitello S, Lio D, Candore G, Caruso C. Colonna-Romano G, et al. Among authors: vitello s. Rejuvenation Res. 2008 Apr;11(2):433-9. doi: 10.1089/rej.2008.0664. Rejuvenation Res. 2008. PMID: 18442327
The nACHR4 594C/T polymorphism in Alzheimer disease.
Vasto S, Candore G, Aquino A, Bulati M, Balistreri CR, Grimaldi MP, Ditta V, Colonna-Romano G, Lio D, Vitello S, Barbieri R, Caruso C. Vasto S, et al. Among authors: vitello s. Rejuvenation Res. 2006 Spring;9(1):107-10. doi: 10.1089/rej.2006.9.107. Rejuvenation Res. 2006. PMID: 16608406
33 results